查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378695

寡核苷酸合成市场：按设备和服务、按技术、按核酸、按应用、按最终用户、按地区

Oligonucleotide Synthesis Market,By Equipment and Services (Equipment/Synthesizer, Reagents, Services, ), By Technology, By Nucleic Acid, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 198 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2023 年，全球寡核苷酸合成市场将达到 38.1 亿美元，并预计在预测期内（2023-2030 年）年复合成长率为 10.9%。

报告范围 报告详情
基准年 2022年 2023年市场规模 38.1亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期年复合成长率 10.90% 2030年市场规模预测 78.7亿美元
图 1. 2023 年按设备和服务分類的寡核苷酸合成全球市场占有率(%)
寡核苷酸合成市场-IMG1

寡核苷酸疗法彻底改变了製药业。寡核苷酸疗法是一类由短 RNA 或 DNA 链组成的药物，可以在合成过程中进行修饰，以改变导致许多疾病的蛋白质的表达。

市场相关人员有兴趣获得监管机构的核准，预计这将在预测期内推动全球寡核苷酸合成市场的成长。例如，2021年，美国食品药物管理局核准了Inclisiran。 Inclisiran 是由製药公司诺华公司 (Novartis AG) 的子公司 Medicines Company 开发的，该公司已从美国生物製药公司 Alnylam Pharmaceuticals 获得了 inclisiran 的权利。 Inclisiran 是一种心血管疾病治疗药物，它显示了寡核苷酸作为针对心血管疾病、肿瘤和代谢疾病等常见疾病的大量患者群体的治疗方法的潜力。我是。目前，不少厂商正在针对寡核苷酸药物的开发进行研发。

市场动态

市场参与者正在从事收购等无机活动，以扩大基本客群。预计这将对预测期内全球寡核苷酸合成市场的成长产生正面影响。例如，2021年1月，英国阶段生物技术公司Sixfold Bioscience与多学科计划OLIGOMED宣布合作开发寡核苷酸疗法。 Sixfold Biosciences 也将接收来自创新培训网络 (ITN) 的博士生 Marie Sklodowska-Curie，她将参与阶段研究 (ESR)，以改进 Sixfold 的体内寡核苷酸递送技术。

本研究的主要特点

  • 本报告详细分析了全球寡核苷酸合成市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率。
  • 它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球寡核苷酸合成市场的主要企业。
  • 该报告的见解将使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
  • 全球寡核苷酸合成市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球寡核苷酸合成市场的各种策略矩阵来促进他们的决策。

目录

第1章调查目的和假设

  • 研究目标
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第3章市场动态、法规及趋势分析

    • 市场动态
    • 促进因素
    • 抑制因素
    • 市场机会
    • 影响分析
    • 最近测试启动
    • 流行病学
    • 合併、收购和合作
    • 监管场景
    • 主要进展
    • PEST分析

第4章全球寡核苷酸合成市场-新型冠状病毒感染疾病（COVID-19）影响分析

    • 经济影响
    • 新型冠状病毒感染疾病（COVID-19）的流行病学
    • 对需求和供给的影响

第5章全球寡核苷酸合成市场，依设备及服务划分，2018-2030

  • 设备和服务
  • 试剂
  • 服务

第6章全球寡核苷酸合成市场（依技术），2018-2030

  • 柱基
  • 微阵列基底

第7章全球寡核苷酸合成市场（依核酸），2018-2030

  • DNA
  • RNA

第8章全球寡核苷酸合成市场（依应用），2018-2030

  • 药物研发
  • 治疗

第9章全球寡核苷酸合成市场，按最终用户划分，2018-2030 年

  • 学术研究所
  • 诊断实验室
  • 製药生物技术公司

第10章2018-2030年全球寡核苷酸合成市场（按地区）

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第11章竞争形势

  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Twist Bioscience
    • STA Pharmaceutical Co. Ltd.
    • KINOVATE LIFE SCIENCES
    • CUSABIO TECHNOLOGY LLC
    • Synbio Technologies
    • GENEWIZ
    • Agilent Technologies, Inc.
    • Maravai LifeSciences Holdings, Inc.
    • Biogen
    • Eurofins Scientific
    • Sarepta Therapeutics, Inc.
    • LGC Limited
    • Kaneka Corporation
    • Biotage
    • Nitto Denko Corporation

第12章章节

  • 参考
  • 调查方法
简介目录
Product Code: CMI4257

The global oligonucleotide synthesis market is estimated to be valued at US$ 3.81 Billion in 2023 and is expected to exhibit a CAGR of 10.9% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 3.81 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 10.90% 2030 Value Projection: US$ 7.87 Bn
Figure 1. Global Oligonucleotide Synthesis Market Share (%), By Equipment and Services, 2023
Oligonucleotide Synthesis Market - IMG1

Oligonucleotide therapeutics have revolutionized the pharmaceutical industry. They are a class of drugs and are composed of short strands of RNA or DNA that can be modified during synthesis in order to alter the expression of a number of disease-causing proteins.

Market players are interested in receiving approval from the regulatory authorities, and this is expected to drive the growth of the global oligonucleotide synthesis market over the forecast period. For instance, in the year 2021, the U.S. Food and Drug Administration approved Inclisiran. Inclisiran is being developed by the Medicines Company, a subsidiary of Novartis AG, a pharmaceutical company, which licensed the rights to inclisiran from Alnylam Pharmaceuticals, an American biopharmaceutical company. Inclisiran is indicated for the treatment of cardiovascular disease and thus demonstrates the opportunity oligonucleotides present as a treatment modality for large patient populations targeting a breadth of common diseases, including cardiovascular disease, oncology, and metabolic disorders. Currently, a number of manufacturers are conducting research and development activities for the development of oligonucleotide drugs.

Market Dynamics

Market players are engaged in conducting inorganic activities such as acquisitions in order to increase their customer base. This is expected to have a positive impact on the growth of the global oligonucleotide synthesis market over the forecast period. For instance, in January 2021, Sixfold Bioscience, a U.K.-based preclinical-stage biotechnology company, and OLIGOMED, a multidisciplinary project, announced a partnership to develop oligonucleotide therapeutics. Sixfold Bioscience also received funding from Marie Sklodowska-Curie, Innovative Training Network (ITN) to enroll PhD students in early-stage research (ESR) to improve Sixfold's in vivo oligonucleotide delivery technology.

Key features of the study:

  • This report provides an in-depth analysis of the global oligonucleotide synthesis market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global oligonucleotide synthesis market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Twist Bioscience, STA Pharmaceutical Co. Ltd., KINOVATE LIFE SCIENCES, CUSABIO TECHNOLOGY LLC, Synbio Technologies, GENEWIZ, Agilent Technologies, Inc., Maravai LifeSciences Holdings, Inc., Biogen, Eurofins Scientific, Sarepta Therapeutics, Inc., LGC Limited, Kaneka Corporation, Biotage and Nitto Denko Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global oligonucleotide synthesis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oligonucleotide synthesis market

Oligonucleotide Synthesis Market Detailed Segmentation:

  • By Equipment and Services:
    • Nucleic Acid Synthesizer
    • Peptide Synthesizer
    • Oligo synthesis
    • Modification
    • Purification
    • Equipment/Synthesizer
    • Reagents
    • Services
  • By Technology:
    • Column-based
    • Microarray-based
  • By Nucleic Acid:
    • DNA
    • RNA
  • By Application:
    • Drug Discovery
    • Therapeutics
  • By End User:
    • Academic Research Institutes
    • Diagnostic Laboratories
    • Pharmaceutical-biotechnology Companies
  • By Region:
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Twist Bioscience
    • STA Pharmaceutical Co. Ltd.
    • KINOVATE LIFE SCIENCES
    • CUSABIO TECHNOLOGY LLC
    • Synbio Technologies
    • GENEWIZ
    • Agilent Technologies, Inc.
    • Maravai LifeSciences Holdings, Inc.
    • Biogen
    • Eurofins Scientific
    • Sarepta Therapeutics, Inc.
    • LGC Limited
    • Kaneka Corporation
    • Biotage
    • Nitto Denko Corporation

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Equipment and Services
    • Market Snippet, By Technology
    • Market Snippet, By Nucleic Acid
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Recent Test Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis

4. Global Oligonucleotide Synthesis Market - COVID-19 Impact Analysis

    • Economic Impact
    • COVID-19 Epidemiology
    • Impact on Supply and Demand

5. Global Oligonucleotide Synthesis Market, By Equipment and Services, 2018- 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Equipment and Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
    • Nucleic Acid Synthesizer
    • Peptide Synthesizer
  • Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
    • Oligo Synthesis
    • Modification
    • Purification

6. Global Oligonucleotide Synthesis Market, By Technology, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • ColuBn-based
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Microarray-based
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

7. Global Oligonucleotide Synthesis Market, By Nucleic Acid, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • DNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • RNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

8. Global Oligonucleotide Synthesis Market, By Application, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Therapeutics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

9. Global Oligonucleotide Synthesis Market, By End User, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Academic Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Pharmaceutical-biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

10. Global Oligonucleotide Synthesis Market, By Region, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific Inc.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Merck KGaA
    • Danaher Corporation
    • Twist Bioscience
    • STA Pharmaceutical Co. Ltd.
    • KINOVATE LIFE SCIENCES
    • CUSABIO TECHNOLOGY LLC
    • Synbio Technologies
    • GENEWIZ
    • Agilent Technologies, Inc.
    • Maravai LifeSciences Holdings, Inc.
    • Biogen
    • Eurofins Scientific
    • Sarepta Therapeutics, Inc.
    • LGC Limited
    • Kaneka Corporation
    • Biotage
    • Nitto Denko Corporation

12. Section

  • References
  • Research Methodology
  • About us and Sales Contact